Navigation Links
Nephros Announces Rights Offering and Temporary Reduction in Exercise Price for March 2011 Warrants
Date:4/17/2013

order to continue operations;
  • a default under the terms of the secured note with Lambda Investors would result in the lender foreclosing upon substantially all of our assets and could result in our inability to continue business operations;
  • we may not be able to complete the contemplated rights offering which could result in our inability to continue business operations;
  • even if we are able to complete the rights offering, we may not have sufficient capital to successfully implement our business plan;
  • restrictions in the secured note and related security agreement which require the prior consent of the lender may restrict our ability to operate our business, sell the company or sell our assets;
  • we may not be able to effectively market our products;
  • we may not be able to sell our water filtration products or chronic renal failure therapy products at competitive prices or profitably;
  • we may encounter problems with our suppliers and manufacturers;
  • we may encounter unanticipated internal control deficiencies or weaknesses or ineffective disclosure controls and procedures;
  • we may not obtain appropriate or necessary regulatory approvals to achieve our business plan;
  • products that appeared promising to us in research or clinical trials may not demonstrate anticipated efficacy, safety or cost savings in subsequent pre-clinical or clinical trials;
  • we may not be able to secure or enforce adequate legal protection, including patent protection, for our products; and
  • we may not be able to achieve sales growth in key geographic markets.
  • More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements, including the forward-looking statements in this press release, is set forth in our filings with the SEC, including our other periodic reports filed with the SEC.  We urge yo
    '/>"/>

    SOURCE Nephros, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5

    Related medicine technology :

    1. Nephros Reports 2012 Fourth Quarter and Full Year Financial Results
    2. Nephros Completes Bridge Financing
    3. Nephros and Chem-Aqua Announce Distribution Agreement
    4. Nephros Reports Third Quarter 2012 Financial Results
    5. Nephros Reports Second Quarter 2012 Financial Results
    6. Nephros Reports First Quarter 2012 Financial Results
    7. Nephros Receives 510(k) Clearance for Hemodiafiltration System
    8. Nephros Appoints John C. Houghton as President and Chief Executive Officer
    9. Creekridge Capital Announces Record Volume
    10. Veracyte Announces That New Study Suggests The Number Of Patients At Risk For Unnecessary Thyroid Surgery Is Likely On The Rise
    11. Rochester Medical Announces Second Quarter 2013 Earnings Conference Call Thursday, April 25, 2013
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/23/2015)... , Jan. 23, 2015  Mallinckrodt plc (NYSE: ... has approved a share repurchase program. The open-ended authorization ... of Mallinckrodt plc ordinary shares. "Funding ... top priorities as we continue to pursue a range ...
    (Date:1/22/2015)... , Jan. 22, 2015  ViewRay™, a privately held ... into an exclusive distributor agreement with ITOCHU Corporation (Tokyo ... therapy system for the treatment of cancer in ... system, is the world,s first and only MRI-guided radiation ...
    (Date:1/22/2015)... 22, 2015 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ("Pivotal" or ... Omega-3 therapies for cardiovascular disease and overall health is pleased ... in 2014 and its outlook for 2015 from the CEO, ... We would like to take this opportunity to ...
    Breaking Medicine Technology:Mallinckrodt plc Announces Share Repurchase Program 2Mallinckrodt plc Announces Share Repurchase Program 3Mallinckrodt plc Announces Share Repurchase Program 4ITOCHU Named the Exclusive Distributor for ViewRay's MRI-Guided Radiation Therapy System in Japan 2Pivotal Therapeutics: Year in Review and CEO Update 2Pivotal Therapeutics: Year in Review and CEO Update 3Pivotal Therapeutics: Year in Review and CEO Update 4Pivotal Therapeutics: Year in Review and CEO Update 5Pivotal Therapeutics: Year in Review and CEO Update 6Pivotal Therapeutics: Year in Review and CEO Update 7
    ... Advocate Christ,Medical Center in Oak Lawn, Ill. has ... area, the only one in the Advocate Health Care ... a glue-like liquid for,the successful treatment of brain aneurysms ... J. Grobelny MD, of,the medical center,s Neurosciences Institute, led ...
    ... 19 Trubion Pharmaceuticals Inc.,(Nasdaq: TRBN ) ... (NYSE: WYE ), has exercised its option ... to extend the research period for an,additional one-year ... of the,research period extension, Wyeth,s obligations to Trubion ...
    Cached Medicine Technology:Advocate Christ Medical Center Using Glue-Like Liquid to Seal Off Brain Aneurysms 2Trubion Pharmaceuticals Announces Extension of Research Period Under Its Wyeth Collaboration 2Trubion Pharmaceuticals Announces Extension of Research Period Under Its Wyeth Collaboration 3
    (Date:1/22/2015)... AngelWeddingDress, the premier women’s dress supplier, ... dresses. View website of AngelWeddingDress.com to find ... wedding dresses online for a bridal party. AngelWeddingDress offers ... for them. Its maternity wedding dresses are specially designed ...
    (Date:1/22/2015)... has released a new blog post explaining the main features ... , Auto insurance quotes help many drivers find the best ... call an agent or visit an agency for price information. ... http://autocarinsurancebest.com/ . , Every business who relies heavily on ...
    (Date:1/22/2015)... La Jolla, Calif. (PRWEB) January 22, 2015 ... and Assemblymembers Susan Bonilla (D-Concord) and Kristin Olsen ... (CHI) for their leadership in advancing biotechnology, biomedical ... Mitchell, Bonilla and Olsen each received the “2014 ...
    (Date:1/22/2015)... 22, 2015 EBSCO Information Services ... expanding their relationship in an effort to further promote visibility ... While EBSCO has long made AMA journals available via its ... for The JAMA Network. , Long known as ...
    (Date:1/22/2015)... (PRWEB) January 22, 2015 Step into ... at the Science Museum of Virginia. Wicked Plants, the ... Wicked Plants unearths 75 poisonous, carnivorous and diabolical plants ... each room to uncover the biochemical, physical and neurological ...
    Breaking Medicine News(10 mins):Health News:AngelWeddingDress Has Recently Released Its Collection Of 2015 Maternity Wedding Dresses 2Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3Health News:EBSCO Expands Partnership with the American Medical Association 2Health News:EBSCO Expands Partnership with the American Medical Association 3Health News:EBSCO Expands Partnership with the American Medical Association 4Health News:Wicked Plants are taking over the Science Museum of Virginia 2
    ... of tobacco, alcohol, drugs may affect kids into early adolescence, ... born to women who use cocaine, alcohol or tobacco during ... adolescence, a new U.S. study says. , Researchers at Children,s ... to study the brains of 35 children, average age 12, ...
    ... N.C., April 7, 2008 MedCath,Corporation (Nasdaq: ... and Edward,R. Casas have been appointed to its ... and Chief Executive Officer for,Personal Care Products Council, ... the MedCath Board of Directors. She has served ...
    ... (Nasdaq: BPUR ) announced today that it ... Commission on Human Medicines addressing,the company,s application for ... pending with the Medicines and,Healthcare products Regulatory Agency ... Commission was "reassured" on a,number of the questions ...
    ... PALO ALTO, Calif., April 7, 2008 Varian, ... Oxford Diffraction,Ltd., a privately owned company based in ... crystallography, an analytical technique used by,scientists in pharmaceutical ... of both small molecules and large molecules such ...
    ... are neglected before their second birthday display higher levels ... to a University of North Carolina at Chapel Hill ... , Early child neglect may be as important as ... accounts for nearly two-thirds of all child maltreatment cases ...
    ... found 3 clays that beat back toughest germs ... like dirt might one day be better than soap ... report they have found a host of anti-microbial minerals ... new generation of unconventional but effective creams to combat ...
    Cached Medicine News:Health News:Fetal Exposure to Substance Abuse Changes Brain Structure 2Health News:Pamela G. Bailey and Edward R. Casas, M.D. Appointed to MedCath's Board of Directors 2Health News:Pamela G. Bailey and Edward R. Casas, M.D. Appointed to MedCath's Board of Directors 3Health News:Biopure Receives Comment Letter From U.K. Regulatory Body on Marketing Application for Hemopure(R) 2Health News:Biopure Receives Comment Letter From U.K. Regulatory Body on Marketing Application for Hemopure(R) 3Health News:Biopure Receives Comment Letter From U.K. Regulatory Body on Marketing Application for Hemopure(R) 4Health News:Varian, Inc. Acquires Oxford Diffraction, Ltd. 2Health News:Varian, Inc. Acquires Oxford Diffraction, Ltd. 3Health News:Early neglect predicts aggressive behavior in children 2Health News:Mud Harnessed to Fight Infections 2Health News:Mud Harnessed to Fight Infections 3
    ... cutting speeds (guillotine movements) are possible. Cutting ... off, thus minimizing tissue trauma. One can ... both can be combined together. There are ... bi-manual techniques. Lightweight autoclavable hand-pieces with single ...
    A wide selection of bipolar forceps and hemostatic erasers to facilitate most ophthalmic surgical procedures....
    Enables Delicate Lifting Of The Flap Without Causing Trauma - Also available in Titanium...
    The CGIL iridectomy contact glass was designed by Riquin, Fankhauser et al. to perform full thickness peripheral laser iridectomies....
    Medicine Products: